Freenome, Siemens Join Forces to Develop Blood Test for Breast Cancer
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
Monitoring transepidermal water loss and hydration identified high-risk skin flaps within the first three postoperative days, potentially enabling earlier intervention.